Key considerations for commercialisation of your advanced therapy research
The virtual event comprises a series of talks, breakouts and panel discussion on the key considerations for commercialisation and translation of cell and gene therapy research, and how to prepare and ensure commercial success for your advanced therapy projects.

Sessions include: Overcoming barriers to scale-up manufacturing, Addressing current and future pre-clinical ATMP development and regulatory needs and Considering your intellectual property and commercial needs
Date: 21 October 2020, 13:00 (Wednesday, 2nd week, Michaelmas 2020)
Venue: After registration via EventBrite, you will receive an access link to the virutal event up to one week before the event sent to the email address provided during registration.
Speaker: Various Speakers
Organising department: Medical Sciences Division
Organisers: Cell and Gene Therapy Catapult, Translational Research Office (Medical Sciences Division, University of Oxford)
Organiser contact email address: translationalresearchoffice@medsci.ox.ac.uk
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/cgt-catapult-advanced-therapies-seminar-with-the-university-of-oxford-registration-122404072877
Audience: Members of the University only
Editor: Janice Young